A specialty pharmaceutical company has appointed a new VP human resources.
A subsidiary of Johnson & Johnson and Gilead Sciences will collaborate to develop a combination drug for HIV, the two companies said Tuesday.
The Food and Drug Administration has accepted a resubmission by Endo Pharmaceuticals of a regulatory application for an opioid pain drug designed to thwart abuse, Endo said.
A Food and Drug Administration expert panel has recommended approval of a drug made by Shire for a rare immune system disorder, the drug maker said.
The Food and Drug Administration has approved a medication designed to treat acute and chronic moderate to severe pain, where the use of an opioid analgesic is suitable.
ProStrakan has received approval from the Food and Drug Administration to market an ointment designed to treat moderate to severe pain associated with chronic anal fissures.
Omnicare has added two members to its board of directors.
Axium Healthcare Pharmacy was named the recipient of a 2011 SMART Award in the healthcare and life sciences category by the Association for Corporate Growth's Orlando chapter, the specialty pharmacy provider announced last week.
A panel of Food and Drug Administration experts has recommended approval of an investigational biotech drug made by Regeneron Pharmaceuticals for eye diseases.
The Food and Drug Administration has approved a new formulation of an injectable drug made by Abbott for prostate cancer.